Navigation Links


Research and Markets - Global Spinal Implants Market to Reach $17.27 Billion by 2021 - Key Vendors are Globus Medical, RTI Surgical & Stryker Corporation

12/5/2016
DUBLIN , Dec 5, 2016 Research and Markets has announced the addition of the "Spinal Implants and Surgical Devices Market - Global Forecast to 2021" report to their offering. The global spinal implants and surgical devices market is estimated to reach 17.27 billion by 2021, at a CAGR of 5.3% from 2016 to 2021. Factors such as the presence of a la... [Comments]

Global Female Fertility and Pregnancy Rapid Test Market to Growe 4% by 2022 - Easy to Use at Home Diagnostic Devices Fueling Growth - Research and Markets

12/5/2016
DUBLIN , Dec 5, 2016 Research and Markets has announced the addition of the "Global Female Fertility and Pregnancy Rapid Test Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering. The global female fertility and pregnancy rapid test market is expected to grow at a CAGR of 4.5% during 2016-2022. The global... [Comments]

Seno Medical Instruments to Present Updated Data from Pivotal European Study at 2016 San Antonio Breast Cancer Symposium

12/5/2016
SAN ANTONIO , Dec. 5, 2016  Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, today announced that it will present data from its European MAESTRO post-market surveillance and clinical follow-up study at the 2016 San Antonio Breast Cancer Symposium (SABCS) ta... [Comments]

BioLineRx Presents Positive Phase 2a AML Study and Mechanism-of-Action Data for BL-8040 Oncology Platform at ASH 2016

12/5/2016
TEL AVIV, Israel , December 5, 2016 BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, presents positive Phase 2a correlative data, as well as detailed mechanism-of-action data, for BL-8040, the Company's leading oncology platform at the ongoing 58th American S... [Comments]

PharmaBoardroom Releases 'Healthcare and Life Sciences Review Switzerland'

12/5/2016
LONDON , December 5, 2016 PharmaBoardroom today releases its new 70 page Switzerland Healthcare & Life Sciences Review 2016 . This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland ; a country located at the heart of Europe , home to some of the world's most important international health... [Comments]

Mission Therapeutics Appoints Colin Goddard as Chairman

12/5/2016
CAMBRIDGE, England , December 5, 2016 M ichael Moore Transitions to Deputy Chairman   Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative and other diseases, announces that Dr Colin Goddard has been appointed as non-executive Chairman, effective... [Comments]

Non-Invasive Prenatal Testing (NIPT) Market Worth $5.5 Billion by 2025: Grand View Research, Inc.

12/5/2016
SAN FRANCISCO , December 5, 2016 The global  non-invasive prenatal testing market  is anticipated to reach USD 5.5 billion by 2025, according to a new report by Grand View Research, Inc. Evolution of prenatal testing in the form of noninvasive tests that can serve as an intermediate step between serum screening and invasive diagnostic testing to determine the likel... [Comments]

AOP Orphan and PharmaEssentia Announce Pivotal Phase III Results for Ropeginterferon Alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2016

12/5/2016
VIENNA and TAIPEI, Taiwan , Dec. 5, 2016 At 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response (CHR) PROUD-PV demonstrated a significantly better safety and tolerability profile of ropeginterferon alfa-2b versus HU AOP will submit the data from PROUD-PV and the ongoing long-term follow-up tri... [Comments]

Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis

12/4/2016
CAMBRIDGE, Mass. , Dec. 4, 2016 Blueprint Medicines Corporation (NASDAQ: BPMC ), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced data from its ongoing Phase 1 trial evaluating BLU-285, an investigational medicine for the treatment of patients with advanced systemic mastocytosis (SM). Bluepr... [Comments]

ZIMMER BIOMET (ZBH) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Zimmer Biomet Holdings, Inc.; Encourages all Investors to Contact the Firm for Information

12/4/2016
SAN DIEGO , Dec. 3, 2016 Johnson & Weaver, LLP announces that a class action complaint was filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ZBH )  securities during the period between September 7, 2016 through October 31, 2016 (the "Class Period"). Zimmer Biomet provides musculoskeletal healthcare products and solutions. It designs, manufacture... [Comments]

[next]
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... (PRWEB) , ... December 03, 2016 , ... ... “Fastest growing Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th ... Dallas Hotel, presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, ...
(Date:12/4/2016)... ... ... Responsible dental care hinges on regular brushing of the teeth. However, just brushing ... inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. , ... bad techniques of brushing the teeth in order to prevent cavities," he said. "Children ...
(Date:12/2/2016)... ... ... On Dec. 2, 2016, CURE® magazine will host the 4th Annual MPN ... Heroes—eight individuals who have made a difference in the field of rare blood cancers ... demonstrating leadership within the MPN community and/or a commitment to individual patients. , This ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, a trusted ... 60-day free trial program for all of the company’s desktop riser products. A ... hassle free experience. , FlexiSpot’s unique desktop risers use an advanced dual gas ...
Breaking Medicine News(10 mins):
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 23G x 5/8in (.60 x 16mm)...
... LASIK surgery and other types of refractive ... and/or stromal bed. Flattened tip provides easy ... the flap edge. Multiple ports provide multi-directional ... 22mm). Angled 90 degrees, 7mm from end. ...
... designed for LASIK surgery and other types ... corneal interface and/or stromal bed. Flattened tip ... helps elevate the flap edge. Multiple ports ... x 22mm) Formed 7mm from end. Two ...
... designed for LASIK surgery and other ... irrigate the corneal interface and/or stromal ... under the flap and helps elevate ... multi-directional irrigation. 25G x 7/8in (.50 ...
Medicine Products:
(Date:12/4/2016)... -- A highly innovative, personalized cell-based treatment for a high-risk form of ... oncologists from Children,s Hospital of Philadelphia today reported ... leukemia (ALL). The physician-scientists presented findings at the annual meeting ... . Continue Reading ... ...
(Date:12/2/2016)... Columbia , December 2, 2016 bioLytical Laboratories, un ... la Compañía, el INSTI HIV Self Test , a los miembros de ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
(Date:12/2/2016)... DUBLIN , Dec 2, 2016 Research ... Market Size, Share, Development, Growth and Demand Forecast to 2022" report ... , , ... revenue of $6 billion in 2015, and it is expected to grow ... ultrasound segment is expected to witness faster growth during the forecast period, ...
Breaking Medicine Technology: